Cargando…
Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction
AIMS: Ischaemia–reperfusion injury (IRI) following myocardial infarction remains a challenging topic in acute cardiac care and consecutively arising heart failure represents a severe long‐term consequence. The extent of neutrophil infiltration and neutrophil‐mediated cellular damage are thought to b...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375131/ https://www.ncbi.nlm.nih.gov/pubmed/37190856 http://dx.doi.org/10.1002/ehf2.14403 |
_version_ | 1785078967827431424 |
---|---|
author | Lenz, Max Kiss, Attila Haider, Patrick Salzmann, Manuel Brekalo, Mira Krychtiuk, Konstantin A. Hamza, Ouafa Huber, Kurt Hengstenberg, Christian Podesser, Bruno K. Wojta, Johann Hohensinner, Philipp J. Speidl, Walter S. |
author_facet | Lenz, Max Kiss, Attila Haider, Patrick Salzmann, Manuel Brekalo, Mira Krychtiuk, Konstantin A. Hamza, Ouafa Huber, Kurt Hengstenberg, Christian Podesser, Bruno K. Wojta, Johann Hohensinner, Philipp J. Speidl, Walter S. |
author_sort | Lenz, Max |
collection | PubMed |
description | AIMS: Ischaemia–reperfusion injury (IRI) following myocardial infarction remains a challenging topic in acute cardiac care and consecutively arising heart failure represents a severe long‐term consequence. The extent of neutrophil infiltration and neutrophil‐mediated cellular damage are thought to be aggravating factors enhancing primary tissue injury. Toll‐like receptor 9 was found to be involved in neutrophil activation as well as chemotaxis and may represent a target in modulating IRI, aspects we aimed to illuminate by pharmacological inhibition of the receptor. METHODS AND RESULTS: Forty‐nine male adult Sprague–Dawley rats were used. IRI was induced by occlusion of the left coronary artery and subsequent snare removal after 30 min. Oligonucleotide (ODN) 2088, a toll‐like receptor 9 (TLR9) antagonist, control‐ODN, or DNase, were administered at the time of reperfusion and over 24 h via a mini‐osmotic pump. The hearts were harvested 24 h or 4 weeks after left coronary artery occlusion and immunohistochemical staining was performed. Echocardiography was done after 1 and 4 weeks to determine ventricular function. Inhibition of TLR9 by ODN 2088 led to left ventricular wall thinning (P = 0.003) in association with drastically enhanced neutrophil infiltration (P = 0.005) and increased markers of tissue damage. Additionally, an up‐regulation of the chemotactic receptor CXCR2 (P = 0.046) was found after TLR9 inhibition. No such effects were observed in control‐ODN or DNase‐treated animals. We did not observe changes in monocyte content or subset distribution, hinting towards neutrophils as the primary mediators of the exerted tissue injury. CONCLUSIONS: Our data indicate a TLR9‐dependent, negative regulation of neutrophil infiltration. Blockage of TLR9 appears to prevent the down‐regulation of CXCR2, followed by an uncontrolled migration of neutrophils towards the area of infarction and the exertion of disproportional tissue injury resulting in potential aneurysm formation. In comparison with previous studies conducted in TLR(−/−) mice, we deliberately chose a transient pharmacological inhibition of TLR9 to highlight effects occurring in the first 24 h following IRI. |
format | Online Article Text |
id | pubmed-10375131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103751312023-07-29 Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction Lenz, Max Kiss, Attila Haider, Patrick Salzmann, Manuel Brekalo, Mira Krychtiuk, Konstantin A. Hamza, Ouafa Huber, Kurt Hengstenberg, Christian Podesser, Bruno K. Wojta, Johann Hohensinner, Philipp J. Speidl, Walter S. ESC Heart Fail Original Articles AIMS: Ischaemia–reperfusion injury (IRI) following myocardial infarction remains a challenging topic in acute cardiac care and consecutively arising heart failure represents a severe long‐term consequence. The extent of neutrophil infiltration and neutrophil‐mediated cellular damage are thought to be aggravating factors enhancing primary tissue injury. Toll‐like receptor 9 was found to be involved in neutrophil activation as well as chemotaxis and may represent a target in modulating IRI, aspects we aimed to illuminate by pharmacological inhibition of the receptor. METHODS AND RESULTS: Forty‐nine male adult Sprague–Dawley rats were used. IRI was induced by occlusion of the left coronary artery and subsequent snare removal after 30 min. Oligonucleotide (ODN) 2088, a toll‐like receptor 9 (TLR9) antagonist, control‐ODN, or DNase, were administered at the time of reperfusion and over 24 h via a mini‐osmotic pump. The hearts were harvested 24 h or 4 weeks after left coronary artery occlusion and immunohistochemical staining was performed. Echocardiography was done after 1 and 4 weeks to determine ventricular function. Inhibition of TLR9 by ODN 2088 led to left ventricular wall thinning (P = 0.003) in association with drastically enhanced neutrophil infiltration (P = 0.005) and increased markers of tissue damage. Additionally, an up‐regulation of the chemotactic receptor CXCR2 (P = 0.046) was found after TLR9 inhibition. No such effects were observed in control‐ODN or DNase‐treated animals. We did not observe changes in monocyte content or subset distribution, hinting towards neutrophils as the primary mediators of the exerted tissue injury. CONCLUSIONS: Our data indicate a TLR9‐dependent, negative regulation of neutrophil infiltration. Blockage of TLR9 appears to prevent the down‐regulation of CXCR2, followed by an uncontrolled migration of neutrophils towards the area of infarction and the exertion of disproportional tissue injury resulting in potential aneurysm formation. In comparison with previous studies conducted in TLR(−/−) mice, we deliberately chose a transient pharmacological inhibition of TLR9 to highlight effects occurring in the first 24 h following IRI. John Wiley and Sons Inc. 2023-05-16 /pmc/articles/PMC10375131/ /pubmed/37190856 http://dx.doi.org/10.1002/ehf2.14403 Text en © 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Lenz, Max Kiss, Attila Haider, Patrick Salzmann, Manuel Brekalo, Mira Krychtiuk, Konstantin A. Hamza, Ouafa Huber, Kurt Hengstenberg, Christian Podesser, Bruno K. Wojta, Johann Hohensinner, Philipp J. Speidl, Walter S. Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction |
title | Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction |
title_full | Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction |
title_fullStr | Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction |
title_full_unstemmed | Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction |
title_short | Short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction |
title_sort | short‐term toll‐like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375131/ https://www.ncbi.nlm.nih.gov/pubmed/37190856 http://dx.doi.org/10.1002/ehf2.14403 |
work_keys_str_mv | AT lenzmax shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT kissattila shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT haiderpatrick shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT salzmannmanuel shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT brekalomira shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT krychtiukkonstantina shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT hamzaouafa shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT huberkurt shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT hengstenbergchristian shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT podesserbrunok shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT wojtajohann shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT hohensinnerphilippj shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction AT speidlwalters shorttermtolllikereceptor9inhibitionleadstoleftventricularwallthinningaftermyocardialinfarction |